SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV)
SKBI
SKBI was delisted on the 18th of December, 2015.
11 hedge funds and large institutions have $2.88M invested in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in 2014 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
50% more capital invested
Capital invested by funds: $1.91M → $2.88M (+$962K)
22% more funds holding
Funds holding: 9 → 11 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$158K |
| 2 |
EGA
Eagle Global Advisors
Houston,
Texas
|
+$120K |
| 3 |
Jane Street
New York
|
+$109K |
| 4 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
+$103K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$68.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$9K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5K |
| 3 |
U
UBS
Zurich,
Switzerland
|
-$4K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$406 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BIT
1
BlackRock Institutional Trust
San Francisco,
California
| $1.23M | +$158K | +26,568 | +19% |
|
|
ACM
2
Ativo Capital Management
Chicago,
Illinois
| $454K | +$8K | +1,342 | +2% |
|
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $259K | -$406 | -68 | -0.2% |
|
|
BCM
4
Bridgeway Capital Management
Houston,
Texas
| $178K | – | – | – |
|
|
EGA
5
Eagle Global Advisors
Houston,
Texas
| $148K | +$120K | +20,196 | New |
|
|
6
Jane Street
New York
| $134K | +$109K | +18,255 | New |
|
|
RCM
7
Rotella Capital Management
Bellevue,
Washington
| $127K | +$103K | +17,293 | New |
|
8
California Public Employees Retirement System
Sacramento,
California
| $117K | – | – | – |
|
|
SIM
9
Spark Investment Management
New York
| $110K | +$3.58K | +600 | +4% |
|
|
10
HighTower Advisors
Chicago,
Illinois
| $85K | +$68.9K | +11,545 | New |
|
|
CAM
11
ClariVest Asset Management
San Diego,
California
| $30K | +$24K | +4,016 | New |
|
|
12
Citigroup
New York
| – | -$9K | -1,303 | Closed |
|
|
TRCT
13
Tower Research Capital (TRC)
New York
| – | -$5K | -818 | Closed |
|
|
U
14
UBS
Zurich,
Switzerland
| – | -$4K | -620 | Closed |
|
SKBI Hedge Fund Activity: Q2 2014 in Review
11 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) for Q2 2014, worth a combined $2.88M — up 50% from $1.91M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new SKBI positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was BlackRock Institutional Trust, adding an estimated $158K. The largest seller was Citigroup, exiting entirely with an estimated $9K sold.
- 11 institutional investors held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) as of Q2 2014, up from 9 in Q1 2014.
- Funds reported $2.88M of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) stock for Q2 2014, up 50% quarter-over-quarter.
- 5 funds opened new SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) positions in Q2 2014 and 3 closed out, a net change of +2 holders.
- The largest SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) buyer in Q2 2014 was BlackRock Institutional Trust, an estimated $158K added.
- The largest SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) seller in Q2 2014 was Citigroup, an estimated $9K sold.
Based on aggregated 13F filings for Q2 2014.